Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Oleg V. Kalyuzhin"'
Autor:
Vadim I. Mazurov, Liudmila I. Alekseeva, Irina B. Belyaeva, Igor G. Belenkiy, Artem L. Burulev, Inna Z. Gaydukova, Elena V. Zonova, Oleg V. Kalyuzhin, Olga B. Nesmeyanova, Elvira N. Otteva, Evgeniy A. Trofimov
Publikováno v:
Терапевтический архив, Vol 96, Iss 1, Pp 68-74 (2024)
A meeting of the Expert Council on September 9, 2023 considered the last challenges in the treatment of osteoarthritis (OA) including OA in comorbid patients. Leading experts in rheumatology, traumatology and other relevant disciplines participated i
Externí odkaz:
https://doaj.org/article/279c69022fdf4dcc8c16eda6e0f3da6b
Publikováno v:
Терапевтический архив, Vol 95, Iss 12, Pp 1165-1171 (2023)
Aim. Evaluation of the efficacy and safety of the drug Aterixen® (XC221GI, 1-[2-(1-methylimidazole-4-yl)-ethyl]perhydroazine-2,6-dione), in the treatment of uncomplicated forms of influenza and other ARVI in adults. Materials and methods. The pha
Externí odkaz:
https://doaj.org/article/573070f735b64e71baae090ad1b1c940
Autor:
Oleg V. Kalyuzhin, Aleksandr V. Gorelov, Andrey G. Malyavin, Andrey A. Zaytsev, Elena V. Esaulenko, Ksenia E. Novak, Anatoliy S. Bykov
Publikováno v:
Терапевтический архив, Vol 95, Iss 10, Pp 850-858 (2023)
Aim. To evaluate the efficacy and safety of OM-85 in the treatment of uncomplicated acute respiratory infections (ARI) in adults. Materials and methods. A double-blind, placebo-controlled, multicenter, randomized trial included 556 patients (18–
Externí odkaz:
https://doaj.org/article/1236a3719b4040bc95ac839d709f4dae
Autor:
Ekaterina V. Silina, Natalia E. Manturova, Olga S. Ivanova, Alexander E. Baranchikov, Elena B. Artyushkova, Olga A. Medvedeva, Alexey A. Kryukov, Svetlana A. Dodonova, Mikhail P. Gladchenko, Ekaterina S. Vorsina, Maria P. Kruglova, Oleg V. Kalyuzhin, Yulia G. Suzdaltseva, Victor A. Stupin
Publikováno v:
Molecules, Vol 29, Iss 12, p 2853 (2024)
Purpose of the study: the creation of a dextran coating on cerium oxide crystals using different ratios of cerium and dextran to synthesize nanocomposites, and the selection of the best nanocomposite to develop a nanodrug that accelerates quality wou
Externí odkaz:
https://doaj.org/article/91478443e793414d948f6848d0ce0e41
Publikováno v:
Терапевтический архив, Vol 94, Iss 7, Pp 872-875 (2022)
The specific feature of new coronavirus infection (COVID-19) is high risk of hyperinflammatory response or cytokine storm development, which underly the pathogenesis of several life-threatening conditions and determine the disease outcomes. Pathophys
Externí odkaz:
https://doaj.org/article/3107b7c73a074a7c8c467f6ad1792faa
Publikováno v:
Терапевтический архив, Vol 93, Iss 1, Pp 108-113 (2021)
During a pandemic, nonspecific immunoprophylaxis of SARS-CoV-2 infection and other acute respiratory infections (ARI), which can worsen the course of COVID-19, is increasingly in demand in addition to specific immunization. BCG vaccine appears to be
Externí odkaz:
https://doaj.org/article/95fad924b7e24a6a9f3e5655e1fc8a46
Publikováno v:
International journal of immunopharmacology. 18(11)
We have studied and compared the immunomodulating activities of two muramyl dipeptide (MDP) derivatives: β-heptylglycoside-MDP (C 7 H 15 MDP) and β-hexadecylglycoside-MDP (C 16 H 33 MDP). The amphiphilic derivative C 7 H 15 MDP has been found to be